Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 205
Selected: 0
NCT IDTitle
NCT03479073Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation
NCT02387554Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405
NCT04074551A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
NCT01548157Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
NCT04764201The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
NCT03826641A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects
NCT04325620Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
NCT05450575An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
NCT02243319Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904
NCT03684642Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
NCT03330314Molar Potency Study of HM12460A in Healthy Subjects
NCT02523547Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude
NCT01504581Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects
NCT01830517Diurnal Variation in Hypertensive Stroke Patients
NCT04946903A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
NCT01093729A Study of HM11260C in Healthy Male Subject
NCT05862090A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
NCT04084184A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects
NCT07297693A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers
NCT05598151Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
NCT04775706Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
NCT03713684Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
NCT02205606Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia
NCT02057172Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
NCT04788290An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol
NCT01455571Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors
NCT01894399Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects
NCT03330327Molar Potency Study of HM12470 in Healthy Subjects
NCT04039724Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers
NCT04167553Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
NCT01505777Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
NCT07449754Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
NCT06858397A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
NCT01030315A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects
NCT01869985Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers
NCT05737082A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers
NCT02554136Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816
NCT02011633Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg
NCT03372850Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations
NCT01447797A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin
NCT04510415Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI
NCT05548543A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
NCT03110874Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control
NCT04324918Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
NCT02529800Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers
NCT01822340Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
NCT00986843Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)
NCT05462535An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet
NCT00979563Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies
NCT06174766A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients